Bimodal decompression sickness onset times are not related to dive type or event severity

Human decompression sickness (DCS) is a condition associated with depressurization during underwater diving. Human research dive trial data containing dive outcome (DCS, no-DCS) and symptom information are used to calibrate probabilistic DCS models. DCS symptom onset time information is visualized u...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Computers in biology and medicine 2017-12, Vol.91, p.59-68
Hauptverfasser: King, Amy E., Murphy, F. Gregory, Howle, Laurens E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Human decompression sickness (DCS) is a condition associated with depressurization during underwater diving. Human research dive trial data containing dive outcome (DCS, no-DCS) and symptom information are used to calibrate probabilistic DCS models. DCS symptom onset time information is visualized using occurrence density functions (ODF) which plot the DCS onset rate per unit time. For the BIG292 human dive trial data set, a primary U.S. Navy model calibration set, the ODFs are bimodal, however probabilistic models do not produce bimodal ODFs. We investigate the source of bimodality by partitioning the BIG292 data based on dive type, DCS event severity, DCS symptom type, institution, and chronology of dive trial. All but one variant of data partitioning resulted in a bimodal or ambiguously shaped ODF, indicating that ODF bimodality is not related to the dive type or the DCS event severity. Rather, we find that the dive trial medical surveillance protocol used to determine DCS symptom onset time may have biased the reported event window. Thus, attempts to develop probabilistic DCS models that reproduce BIG292 bimodality are unlikely to result in an improvement in model performance for data outside of the calibration set.
ISSN:0010-4825
1879-0534
DOI:10.1016/j.compbiomed.2017.10.010